<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190805044438N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-30</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>The effect of mirror therapy on the phantom limb pain and sexual satisfaction in men with lower limb amputation</public_title>
      <acronym></acronym>
      <scientific_title>The effect of mirror therapy on the phantom limb pain and sexual satisfaction in men with lower limb amputation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49237</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Individuals are entered into the study according to the study criteria. Individuals are simple randomly assigned to the intervention and control groups with the Random Allocation software. The unit of randomization is individual and study without blinding and parallel.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Amputation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: At the beginning of the study, before starting mirror therapy, the degree of phantom limb pain and sexual satisfaction in individuals will be determined before the session begins. In this method, subjects will be in front of a mirror with dimensions of 30x80 cm, in such a way that the amputated limb is behind the mirror and the healthy limb is in front of the mirror so that the subject can see a clear image of the movements of the healthy limb in the mirror. Each mirror therapy session will be 15 minutes. Subjects will have 5 sessions per week for 28 days. In each session of mirror therapy, 5 minutes will be devoted to opening and closing the healthy foot in front of the mirror, 5 minutes to rotating the ankle inward, and 5 minutes to rotation of the ankle outward. All participants will complete a total of twenty 15-minute sessions. 7, 14 and 21 days after the intervention, the degree of phantom limb pain will be measured by a VAS instrument and on the 28th day after the end of the intervention, sexual satisfaction will also be assessed in addition to the phantom limb pain. After the first session, when the researchers ensured that the patients have learned correctly how to perform mirror therapy, they provided written instructions to the patients so that they could continue the mirror therapy process at home. Every week 2 phone calls were made to review the process, to encourage people to perform the process regularly, and to answer participants' questions. Intervention 2: Control group: No specific intervention by the researcher will be performed on patients in this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is We have not decided yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Roya Mansour-ghanaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Martyr Yaghoub Sheikhi St., Leyla Kooh, Langeroud, Rasht, Iran</address>
        <city>Langeroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4477163485</zip>
        <telephone>+98 13 4256 5058</telephone>
        <email>r_ghanaei@gums.ac.ir</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Roya Mansour-ghanaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Martyr Yaghoub Sheikhi St., Leyla Kooh, Langeroud, Rasht, Iran</address>
        <city>Langeroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4477163485</zip>
        <telephone>+98 13 4256 5058</telephone>
        <email>r_ghanaei@gums.ac.ir</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Married and monogamous men
Age 18 to 60 years old
One-sided amputation of the lower limb at two partial levels (from toes to ankle) or extensive levels (above ankle to thigh)
Pain in the phantom limb with a severity of at least 20
Sufficient cognitive ability according to AMT tool
Informed consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of sexual dysfunction before amputation
Sexual disorder drugs consumption during the study
New analgesics consumption during the study
Thyroid disorders
Malignant diseases
Visual disturbances
Severe hearing loss
Movement disorders or barriers (cast, splint, etc.) in the healthy lower limb</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Y83.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Amputation of limb(s)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: At the beginning of the study, before starting mirror therapy, the degree of phantom limb pain and sexual satisfaction in individuals will be determined before the session begins. In this method, subjects will be in front of a mirror with dimensions of 30x80 cm, in such a way that the amputated limb is behind the mirror and the healthy limb is in front of the mirror so that the subject can see a clear image of the movements of the healthy limb in the mirror. Each mirror therapy session will be 15 minutes. Subjects will have 5 sessions per week for 28 days. In each session of mirror therapy, 5 minutes will be devoted to opening and closing the healthy foot in front of the mirror, 5 minutes to rotating the ankle inward, and 5 minutes to rotation of the ankle outward. All participants will complete a total of twenty 15-minute sessions. 7, 14 and 21 days after the intervention, the degree of phantom limb pain will be measured by a VAS instrument and on the 28th day after the end of the intervention, sexual satisfaction will also be assessed in addition to the phantom limb pain. After the first session, when the researchers ensured that the patients have learned correctly how to perform mirror therapy, they provided written instructions to the patients so that they could continue the mirror therapy process at home. Every week 2 phone calls were made to review the process, to encourage people to perform the process regularly, and to answer participants' questions.</i_keyword>
      <i_keyword>Control group: No specific intervention by the researcher will be performed on patients in this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score in a Pain Visual Analogue Scale. Timepoint: Before intervention and 7, 14, 21 and 28 days after the start of mirror therapy. Method of measurement: Pain Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Scores obtained in the Sexual Satisfaction Questionnaire. Timepoint: Before intervention and 28 days after the start of mirror therapy. Method of measurement: Larson Sexual Satisfaction Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-14</approval_date>
        <contact_name>Ethics committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Deputy of university Research and Technology of the University, Old Bldg (building) School of Health, in front of 17 Shahrivar Hospital, Shahid Siadati Ave, Namjoo St, Rasht Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
